Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hospital Clínico Universitario de Valladolid | OTHER |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | OTHER |
| Hospital Vall d'Hebron | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective, multicenter, randomized clinical trial. Survivors from an out-of-hospital cardiac arrest (OHCA) without ST segment elevation in their EKG will be recruited. Potentially non-cardiac etiology of the cardiac arrest will be ruled out prior to randomization. Primary goal (treatment): to evaluate the efficacy of urgent vs deferred coronary angiography in survivors from OHCA without ST-segment elevation in the EKG.
Prospective, multicenter and randomized clinical trial. Survivors from Out-of-Hospital Cardiac Arrest (OHCA) who do not show ST elevation in their EKG will be recruited in the present study. Potentially non-cardiac ethiology of the cardiac arrest will be ruled out prior to randomization. Afterwards, patients will be randomized to emergent or deferred (performed before discharge) coronary angiography. Both groups will receive routine care in the Acute Cardiac Care Unit, including therapeutic hypothermia.
The randomization will be in a 1:1 ratio to urgent or deferred coronary angiography.
The main objective of the study is to compare the effectiveness of an urgent coronary angiography and angioplasty if necessary versus a deferred coronary angiography in survivors from OHCA who after recovery of spontaneous circulation do not fulfill criteria for ST-elevation myocardial infarction.
The primary efficacy endpoint is a composite of in-hospital survival and six-month survival free of severe dependence, which will be evaluated by using the Cerebral Performance Category (CPC) Scale, being good prognosis represented by the categories 1 and 2.The safety endpoint will be a composite of MACE (Major Adverse Cardiac Events) including: death, reinfarction, bleeding or ventricular arrhythmias.
A total of 166 patients will be included. The estimated duration will be 42 months, with a target follow-up of 6 months. Periods will be divided as follows:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Urgent Coronary Angiography | Experimental | Urgent Coronary Angiography: as soon as possible, when the patient is randomized. |
|
| Deferred coronariography | Active Comparator | Deferred coronary angiography: after extubation if the patient has a good neurologic prognosis. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Urgent Coronary Angiography | Procedure | Diagnostic test for the evaluation of the coronary vasculature. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Survival with good neurological outcome for activities of daily living (CPC 1-2). | Survival with good neurological outcome for activities of daily living (CPC 1-2). | 30 days. |
| Survival with good neurological outcome for activities of daily living (CPC 1-2). | Survival with good neurological outcome for activities of daily living (CPC 1-2). | 6 months. |
| MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias. | MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias. | 30 days. |
| MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias. | MACE: death, myocardial infarction, clinically evident bleeding (BARC> 2) or ventricular arrhythmias. | 6 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Hospital survival. | Hospital survival. | 30 days. |
| Hospital survival. | Hospital survival. | 6 months. |
Not provided
Inclusion Criteria: survivors from out of hospital cardiac arrest who meet all the following criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ana Viana Tejedor, MD, PhD | Hospital Clinico San Carlos | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Clínico San Carlos | Madrid | 28040 | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25195073 | Result | Camuglia AC, Randhawa VK, Lavi S, Walters DL. Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: review and meta-analysis. Resuscitation. 2014 Nov;85(11):1533-40. doi: 10.1016/j.resuscitation.2014.08.025. Epub 2014 Sep 4. | |
| 23479672 | Result | Morrison LJ, Neumar RW, Zimmerman JL, Link MS, Newby LK, McMullan PW Jr, Hoek TV, Halverson CC, Doering L, Peberdy MA, Edelson DP; American Heart Association Emergency Cardiovascular Care Committee, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on P. Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association. Circulation. 2013 Apr 9;127(14):1538-63. doi: 10.1161/CIR.0b013e31828b2770. Epub 2013 Mar 11. No abstract available. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006323 | Heart Arrest |
| D007035 | Hypothermia |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001832 | Body Temperature Changes |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| Hospital Arnau de Vilanova |
| OTHER |
| Hospital Universitari de Bellvitge | OTHER |
| Hospital General Universitario Gregorio Marañon | OTHER |
| Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | OTHER |
| Hospital Universitario Ramon y Cajal | OTHER |
| Hospital Clinic of Barcelona | OTHER |
| Hospital Universitario Virgen Macarena | OTHER |
| Hospital Universitario de Canarias | OTHER |
| Germans Trias i Pujol Hospital | OTHER |
| Complejo Hospitalario Universitario de Santiago | OTHER |
| Hospital Universitario Principe de Asturias | OTHER |
| Hospital Universitari Joan XXIII de Tarragona. | OTHER |
| Hospital de Leon | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
| Deferred Coronary Angiography | Procedure | Diagnostic test for the evaluation of the coronary vasculature. |
|
| Neurological outcome assessed by the Cerebral Performance Category (CPC) Scale. | Neurological outcome assessed by the Cerebral Performance Category (CPC) | 30 days. |
| Neurological outcome assessed by the Cerebral Performance Category (CPC) Scale. | Neurological outcome assessed by the Cerebral Performance Category (CPC) | 6 months. |
| Left ventricular ejection fraction. | Left ventricular ejection fraction. | 30 days. |
| Left ventricular ejection fraction. | Left ventricular ejection fraction. | 6 months. |
| Infarction size | Defined by the maximum CPK (creatine phosphokinase) and Troponin. | 30 days. |
| Vascular complications. | Vascular complications such as pseudoaneurysms, arteriovenous fistulas, etc | 30 days. |
| Clinically evident haemorrhagia: BARC> 2 | Clinically evident haemorrhagia: BARC> 2 | 30 days. |
| Sustained ventricular arrythmias or requirement of cardioversion. | Sustained ventricular arrythmias or requirement of cardioversion. | 30 days. |
| Renal impairment. | A 50% increase of serum creatinine over a baseline level or an increase of >0.5 mg/dl | 30 days. |
| Reinfarction. | According to the Universal Definition of Acute Myocardial Infarction | 30 days. |
| Stent Thrombosis | Defined by the Academic Research Consortium (ARC). | 30 days. |
| Infections. | Infections. | 30 days. |
| Length of intubation. | Length of intubation. | 30 days. |
| Length of hospital stay. | Length of hospital stay. | 6 months. |
| 35750580 | Derived | Viana-Tejedor A, Andrea-Riba R, Scardino C, Ariza-Sole A, Baneras J, Garcia-Garcia C, Jimenez Mena M, Vila M, Martinez-Selles M, Pastor G, Garcia Acuna JM, Loma-Osorio P, Garcia Rubira JC, Jorge Perez P, Pastor P, Ferrera C, Noriega FJ, Perez Macias N, Fernandez-Ortiz A, Perez-Villacastin J; COUPE Investigators. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial. Rev Esp Cardiol (Engl Ed). 2023 Feb;76(2):94-102. doi: 10.1016/j.rec.2022.05.013. Epub 2022 Jun 22. English, Spanish. |
| D013568 |
| Pathological Conditions, Signs and Symptoms |